WallStreetZenWallStreetZen

NASDAQ: EWTX
Edgewise Therapeutics Inc Stock Ownership - Who owns Edgewise Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Edgewise Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Alan J. RussellChief Scientific Officer2025-08-26100,000$0.18
$18.00kBuy
Alan J. RussellChief Scientific Officer2025-08-26100,000$14.60
$1.46MSell
Kevin KochPresident and CEO2025-08-127,972$13.39
$106.76kSell
R. Michael CarruthersChief Financial Officer2025-08-121,428$13.39
$19.12kSell
Behrad DerakhshanChief Business Officer2025-08-122,491$13.39
$33.36kSell
Alan J. RussellChief Scientific Officer2025-08-121,907$13.39
$25.54kSell
John R. 1. MooreGeneral Counsel2025-08-122,098$13.39
$28.10kSell
Joanne M. DonovanCMO2025-08-122,862$13.39
$38.33kSell
R. Michael CarruthersChief Financial Officer2025-05-021,314$16.45
$21.62kSell
Behrad DerakhshanChief Business Officer2025-05-021,691$16.45
$27.82kSell

1 of 4

EWTX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when EWTX insiders and whales buy or sell their stock.

EWTX Shareholders

What type of owners hold Edgewise Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Orbimed Advisors LLC14.73%15,518,492$254.81MInstitution
Ra Capital Management LP9.40%9,902,633$162.60MInstitution
Baker Bros Advisors LP6.94%7,305,940$119.96MInstitution
Blackrock Inc6.44%6,781,046$111.34MInstitution
Paradigm Biocapital Advisors LP5.83%6,142,344$100.86MInstitution
Holdings A. Novo5.76%6,071,703$99.70MInsider
Janus Henderson Group PLC5.22%5,503,349$90.36MInstitution
Novo Holdings A5.08%5,350,000$87.85MInstitution
Braidwell LP4.95%5,210,831$85.56MInstitution
Vanguard Group Inc4.60%4,841,500$79.50MInstitution

1 of 3

EWTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
EWTX88.36%11.64%Net BuyingNet Selling
STOK52.29%47.71%Net SellingNet Selling
CLDX85.11%14.89%Net BuyingNet Selling
GPCR31.63%12.59%Net SellingNet Selling
MNKD35.18%64.82%Net SellingNet Selling
View Top Biotech Stocks

Edgewise Therapeutics Stock Ownership FAQ

Who owns Edgewise Therapeutics?

Edgewise Therapeutics (NASDAQ: EWTX) is owned by 112.71% institutional shareholders, 14.85% Edgewise Therapeutics insiders, and 0.00% retail investors. Holdings A. Novo is the largest individual Edgewise Therapeutics shareholder, owning 6.07M shares representing 5.76% of the company. Holdings A. Novo's Edgewise Therapeutics shares are currently valued at $99.15M.

If you're new to stock investing, here's how to buy Edgewise Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.